What is the recommended treatment for bronchitis, including acute and chronic forms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Bronchitis

For acute bronchitis, antibiotics should NOT be routinely prescribed as this is predominantly a viral illness; treatment focuses on patient education about the expected 2-3 week duration of cough and symptomatic relief only. 1, 2

Acute Bronchitis

Key Diagnostic Considerations

Before treating as acute bronchitis, rule out pneumonia if any of these are present:

  • Heart rate >100 beats/min
  • Respiratory rate >24 breaths/min
  • Temperature >38°C
  • Focal consolidation, egophony, or fremitus on chest exam 1

If these are absent, chest radiograph is not needed.

Treatment Approach

Antibiotics: Do NOT Use

  • Acute bronchitis is viral in >90% of cases 1, 3
  • Antibiotics reduce cough duration by only ~0.5 days while exposing patients to adverse effects including allergic reactions, nausea, and C. difficile infection 3, 4
  • Grade D recommendation: routine antibiotics are not justified 1

Exception: If pertussis is confirmed or strongly suspected (paroxysmal cough, whooping, post-tussive vomiting, known exposure), prescribe a macrolide antibiotic (erythromycin or azithromycin) and isolate patient for 5 days 1

Bronchodilators: Generally Not Recommended

  • β2-agonists should NOT be routinely used 1, 2
  • May consider in select patients with wheezing at presentation, suggesting underlying reactive airways 1

Other Therapies: Not Recommended The following have insufficient evidence and should NOT be routinely prescribed 2, 3:

  • Antitussives (codeine, dextromethorphan)
  • Inhaled anticholinergics
  • Inhaled or oral corticosteroids
  • Oral NSAIDs
  • Antihistamines
  • Honey

What TO Do

  1. Patient education - Emphasize cough typically lasts 2-3 weeks 3, 4
  2. Symptomatic relief only - Rest, hydration, over-the-counter supportive care
  3. Reassessment if worsens - Consider bacterial superinfection or alternative diagnosis 2

Communication Strategy

  • Refer to the condition as a "chest cold" rather than "bronchitis" to reduce antibiotic expectations 3, 4
  • If patient pressure is high, consider delayed antibiotic prescription (to be filled only if symptoms worsen after 5-7 days) 4

Chronic Bronchitis (Stable)

For stable chronic bronchitis, first-line treatment is short-acting β-agonists and ipratropium bromide for bronchodilation and cough control; the single most important intervention is complete avoidance of respiratory irritants, especially smoking cessation. 5

Risk Factor Modification (Most Important)

  • Smoking cessation is paramount - more effective than any pharmacologic therapy 5, 6
  • Avoid dusty environments, irritating inhalants, and environmental pollutants 6

Pharmacologic Treatment

Bronchodilators (Grade A Recommendations):

  1. Short-acting β-agonists - Control bronchospasm, relieve dyspnea, may reduce chronic cough 5

  2. Ipratropium bromide - Reduces cough frequency and severity, decreases sputum volume 5

  3. Theophylline - Consider for chronic cough control, but requires careful monitoring for side effects (especially in elderly) and drug interactions 5

Inhaled Corticosteroids:

  • Reserve for patients with FEV1 <50% and/or frequent exacerbations 5
  • Combined long-acting β-agonist + inhaled corticosteroid reduces exacerbation rates 5

NOT Recommended for Stable Disease:

  • Prophylactic antibiotics 5
  • Oral corticosteroids 5
  • Expectorants (no proven benefit) 5
  • Postural drainage or chest percussion 5
  • Mucokinetic agents 6

Acute Exacerbation of Chronic Bronchitis

For acute exacerbations, use short-acting β-agonists or anticholinergic bronchodilators first; add antibiotics if bacterial infection is likely (increased sputum purulence/volume); and prescribe a 2-week course of systemic corticosteroids. 5

Treatment Algorithm

Step 1: Bronchodilators (Grade A)

  • Start with short-acting β-agonist OR anticholinergic
  • If inadequate response, add the other agent at maximal dose 5
  • Do NOT use theophylline during acute exacerbations (Grade D) 5

Step 2: Antibiotics (Grade A)

  • Indicated for patients with bacterial exacerbation (increased sputum purulence, increased sputum volume, worsening dyspnea) 5
  • Patients with severe exacerbations and baseline severe airflow obstruction benefit most 5
  • Advanced antibiotics preferred: fluoroquinolones (levofloxacin, moxifloxacin), macrolides, or amoxicillin-clavulanate 7, 8
  • Duration: 5 days is adequate for most patients 8

Step 3: Systemic Corticosteroids (Grade A)

  • Oral or IV corticosteroids improve outcomes 5
  • Duration: 2 weeks (equivalent to 8 weeks with fewer side effects) 5

NOT Recommended During Exacerbations:

  • Mucokinetic agents/expectorants 5
  • Postural drainage or chest percussion 5
  • Theophylline 5

Common Pitfall

Do not confuse acute bronchitis (viral, self-limited) with acute exacerbation of chronic bronchitis (often bacterial, requires antibiotics). The latter occurs in patients with established chronic bronchitis who experience sudden worsening with increased sputum purulence/volume.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.